A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)
Clinical trial NCT02409355 · TERMINATED
Trial details
- NCT number
- NCT02409355
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-07
- Primary completion
- 2017-12-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.